In an effort to enhance the healthcare sector, AstraZeneca, along with its partners, has successfully trained more than 10,600 healthcare professionals.

This milestone was revealed in a statement titled ‘Healthy Heart Africa marks nine years of impact addressing the burden of hypertension in Sub-Saharan Africa.’

The statement also emphasized the significance of Public Private Partnerships (PPPs) for Africa’s development.

On World Heart Day, AstraZeneca and its partners marked nine years of progress in the battle against hypertension, contributing to the reduction of cardiovascular diseases and non-communicable diseases through the Healthy Heart Africa program.

Since its establishment in 2014, the program has achieved numerous milestones, including conducting over 38.5 million blood pressure screenings, diagnosing more than 3.1 million individuals, and training over 10,600 healthcare workers.

ALSO READ: Abia governor reaffirms commitment to enhanced healthcare services

These healthcare professionals, including doctors, nurses, community health volunteers, and pharmacists, have been equipped to provide education, awareness, screening, and treatment services. Additionally, the program has activated over 1,300 healthcare facilities to offer hypertension services.

To commemorate the program’s nine-year anniversary, AstraZeneca and its partners organized a webinar to assess the achievements to date and discuss future strategies for addressing the growing burden of cardiovascular diseases and non-communicable diseases in Africa.

The discussion also delved into the role of public-private partnerships in supporting primary healthcare, drawing insights from the Healthy Heart Africa program.

Qutaiba Al Manaseer, Senior Director of Corporate Affairs for the Middle East & Africa Region at AstraZeneca, stated, “Healthy Heart Africa demonstrates the power of public-private partnerships in delivering sustainable solutions that strengthen the resilience of local health systems.

We will continue collaborating with stakeholders to tackle the silent killer that is hypertension and to improve patient outcomes.”